课题基金 / 基金详情

Diagnostic and prognostic biomarkers for epithelial ovarian cancer

Diagnostic and prognostic biomarkers for epithelial ovarian cancer
上皮性卵巢癌的诊断和预后生物标志物
批准号:
172026
负责人:
Jurisica Igor
金额:
$46.9万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-09-01 至 2012-09-01

项目摘要

项目成果

Jurisica Igor的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mortality rate from epithelial ovarian cancer (EOC) is higher than that of any other cancer among women in the North America, with staggering 63%. Currently, 75% of new cases are not diagnosed until the disease is in its late stages of development, when
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-level integrative 'omics to identify biomarkers in a Schizophrenia and other major psychoses. Jeremie Poschmann. Muliobio
  • 批准号:
    406868
  • 项目类别:
    Operating Grants
  • 资助金额:
    $16.39万
  • 财政年份:
    2019
  • 负责人:
    Jurisica Igor
  • 依托单位:
CRC Tier 1
  • 批准号:
    241506
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2010
  • 负责人:
    Jurisica Igor
  • 依托单位:
Tools for efficient and effective network-based prediction of diagnostic and prognostic cancer signatures
  • 批准号:
    182263
  • 项目类别:
    Operating Grants
  • 资助金额:
    $6.86万
  • 财政年份:
    2009
  • 负责人:
    Jurisica Igor
  • 依托单位:
海外基金